Practically Speaking: Managing the Toxic Bite of BiTEs

To be added to the distribution list, please email: DDeCastro@southlakeregional.org

In this episode, Dr. Philip Kuruvilla takes us through the Implementation of Bispecific Antibody therapies into a community setting, focusing on management of toxicities of interest specifically Cytokine Release Syndrome (CRS) and Immune Cell Associated Neurotoxicity Syndrome (ICANS). 

Key Opinion Leader: 
Philip Kuruvilla, MD.  Assistant Clinical Professor (Adjunct) McMaster University
Medical Oncologist
Interim Division Chief Hematology - William Osler Health System

Host:
Shaqil Kassam MD. MSc. FRCPC
skassam@southlakeregional.org
Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Previous episodes: https://www.blogtalkradio.com/medoncnow